Leadership Overview
Tessolve has 4 executives leading key functions including finance, operations, human resources, and co-founder leadership.
Driven by innovation, Tessolve provides a one-stop-shop solution with full-fledged hardware and software capabilities, including advanced silicon and system testing labs, to deliver efficient turnkey solutions for silicon bring-up and product development.
Driven by innovation, Tessolve provides a one-stop-shop solution with full-fledged hardware and software capabilities, including advanced silicon and system testing labs, to deliver efficient turnkey solutions for silicon bring-up and product development.
Leadership Roles at Tessolve
Raghavendra Jha - Chief Financial Officer
Raghavendra Jha, the Chief Financial Officer at Tessolve, directs all financial strategy and fiscal operations. Overseeing budgeting, forecasting, and financial reporting, Jha ensures robust financial health and compliance across the organization. This leadership role involves managing capital allocation, investor relations, and driving profitability through strategic financial planning. By optimizing financial processes and mitigating risks, Raghavendra Jha directly supports Tessolve's growth objectives and market expansion. Jha's expertise in financial management is critical for sustaining the company's operational efficiency and long-term economic stability, aligning fiscal performance with the company's mission of delivering efficient turnkey solutions for silicon bring-up and product development.

Ravi Chirugudu - President & Chief Operating Officer
Ravi Chirugudu, the President & Chief Operating Officer at Tessolve, executes the company's operational strategy and oversees day-to-day business functions. Chirugudu directs global operations, ensuring seamless integration of hardware and software capabilities to deliver comprehensive silicon bring-up and product solutions. This critical role involves optimizing resource allocation, enhancing operational efficiency, and driving process improvements across all departments. By managing the company's extensive silicon and system testing labs, Ravi Chirugudu ensures the highest standards of quality and performance. Chirugudu's leadership is pivotal in translating Tessolve's vision into tangible results, fostering a culture of excellence and continuous improvement to meet client demands for efficient, end-to-end product development.
Veerappan Vv - Co-Founder & President
Veerappan Vv, the Co-Founder & President at Tessolve, provides strategic vision and leadership, guiding the company's overall direction and market positioning. Vv champions the company's mission to deliver efficient turnkey solutions, leveraging Tessolve's unique combination of pre-silicon and post-silicon expertise. This foundational role involves fostering key partnerships, driving innovation across hardware and software capabilities, and ensuring the company's advanced silicon and system testing labs remain at the forefront of the industry. By setting the strategic agenda, Veerappan Vv ensures Tessolve consistently meets the evolving needs of clients seeking comprehensive product development from specification to launch. Vv's enduring commitment fuels Tessolve's growth and its reputation as a leader in silicon bring-up.

Renil Kumar - Chief Human Resources Officer
Renil Kumar, the Chief Human Resources Officer at Tessolve, architects the company's human capital strategy and cultivates a high-performance organizational culture. Kumar oversees talent acquisition, development, and retention initiatives, ensuring Tessolve attracts and retains top engineering and technical talent essential for its advanced silicon and system testing labs. This leadership position involves shaping employee engagement programs, managing compensation and benefits, and fostering an inclusive work environment that supports innovation. By aligning HR policies with business objectives, Renil Kumar drives employee satisfaction and productivity, directly contributing to the company's ability to deliver efficient turnkey solutions. Kumar's focus on people empowers Tessolve's workforce to excel in pre-silicon and post-silicon expertise.

Explore Leadership Teams in Business Services
Rho, founded in 1984, is a privately-held, contract research organization (CRO) located near Chapel Hill, NC. The company provides a full range of clinical research services across the entire drug development process.
Company Leadership LM
MH
SJ
TM
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic.
Company Leadership SY


DL
Mars Veterinary Health is a global veterinary health organization dedicated to providing high-quality preventive, general, specialty, and emergency care across 3,000 clinics worldwide. With a team of nearly 70,000 passionate associates, including over 12,000 veterinarians, they focus on improving the health and wellbeing of pets and supporting veterinary professionals. The company emphasizes innovation and scientific breakthroughs, leveraging advanced technologies and extensive data to enhance veterinary care. Their mission is to create a better world for pets and the people who care for them.
Company Leadership JF

TT

United BioSource LLC (UBC) is a leading provider of pharmaceutical support services, partnering with biopharmaceutical companies to make medicine and specialty therapies safer and more accessible. UBC is well known for our expertise in generating authoritative, real-world evidence of product effectiveness, safety, and value. We specialize in evidence-based research for both emerging and leading pharmaceutical companies with a primary focus on rare diseases, novel indications, and specialty therapies. UBCs focus is to assist healthcare decisions and enhance patient care throughout the entire product lifecycle. We accomplish this through a consultative approach built around decades of epidemiological and operational experience. UBC provides tailored solutions to help your product progress from phase II research, safety and REMS, through post-product launch patient support services and commercialization.
Company Leadership
SB
DR
MH